Skip to content
ANANAN

Drawing based on the label description. No photo yet.

“TRYVIO (aprocitentan) tablets are available as: 12.5 mg: yellow to orange round, film-coated tablet, debossed with "AN" on one side and plain on the other side”

AN pill

Pill with imprint AN is yellow, round, 6 mm and has been identified as Aprocitentan 12.5 mg. It is used for high blood pressure. It is supplied by Idorsia Pharmaceuticals Ltd.

Aprocitentan 12.5 mg

Imprint
AN
Strength
12.5 mg
Used for
High blood pressure
Color
Yellow
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Idorsia Pharmaceuticals Ltd
Drug class
Endothelin receptor antagonist
NDC
80491-8012, 80491-8012-3, 80491-8012-7, 80491-8012-8

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Aprocitentan pills and guides

What is Aprocitentan used for?

Aprocitentan is used for high blood pressure.

Medicine type
Endothelin receptor antagonist
Official uses from the US prescribing label

TRYVIO, in combination with other antihypertensive drugs, is indicated for the treatment of hypertension, to lower blood pressure (BP) in adult patients who are not adequately controlled on other drugs. Lowering BP reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. There are no controlled trials demonstrating reduction of risk of these events with TRYVIO.

Control of high BP should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve BP goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is BP reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher BPs, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from BP reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower BP goal.

From the FDA-approved label on DailyMed (published Aug 20, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows AN and the other side is plain.
  • It is yellow, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Tryvio.

Ingredients

Active: Aprocitentan

Inactive: Croscarmellose Sodium, Hydroxypropyl Cellulose, Unspecified, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose, Ferrosoferric Oxide, Ferric Oxide Red, Ferric Oxide Yellow, Polyvinyl Alcohol, Unspecified, Hydrated Silica, Talc, Titanium Dioxide, Triethyl Citrate

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.